BridgeBio Pharma, Bayer agree on licensing deal for heart disease drug in Europe – Reuters03/04/2024 majac Heart Disease BridgeBio Pharma has granted German drugmaker Bayer an exclusive license to commercialize its heart disease drug in Europe, the companies said on …Share on FacebookTweetFollow usSave